TFF Pharmaceuticals, Inc. Business Finance Contracts & Agreements
21 Contracts & Agreements
- Contribution Agreements (1 contract)
- Purchase Agreements (3)
- Registration Rights Agreements (2)
- Stock Agreements (2)
- Underwriting Agreements (4)
- Warrant Agreements (9)
- Underwriting Agreement dated as of August 14, 2023 between the Company and The Benchmark Company, LLC (Filed With SEC on August 15, 2023)
- Form of Warrant issued to investors in November 2022 Follow-On Offering (Filed With SEC on March 31, 2023)
- Form of Warrant sold in the offering (Filed With SEC on November 18, 2022)
- Underwriting Agreement dated as of November 17, 2022 between the Company and JonesTrading Institutional Services LLC (Filed With SEC on November 18, 2022)
- Underwriting Agreement dated as of March 26, 2021 among the Company, Lung Therapeutics, Inc. and Roth Capital Partners LLC (Filed With SEC on March 26, 2021)
- Description of Capital Stock (Filed With SEC on March 10, 2021)
- Form of Registration Rights Agreement dated August 10, 2020 between the Company and investors named in the Securities Purchase Agreement (Filed With SEC on August 11, 2020)
- Form of Securities Purchase Agreement, dated August 10, 2020, between the Company and Investors named therein (Filed With SEC on August 11, 2020)
- Warrant dated November 20, 2019 issued to National Securities Corporation (Filed With SEC on March 27, 2020)
- Warrant dated October 29, 2019 issued to National Securities Corporation (Filed With SEC on March 27, 2020)
- Specimen Certificate representing shares of common stock of Registrant (Filed With SEC on September 27, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 27, 2019)
- Warrant dated January 24, 2018 issued to Liquid Patent Advisors, LLC (Filed With SEC on August 20, 2019)
- Warrant dated March 13, 2018 issued to National Securities Corporation (Filed With SEC on August 20, 2019)
- Warrant dated March 22, 2018 issued to National Securities Corporation (Filed With SEC on August 20, 2019)
- Warrant dated May 16, 2019 issued to National Securities Corporation (Filed With SEC on August 20, 2019)
- Warrant dated May 23, 2019 issued to National Securities Corporation (Filed With SEC on August 20, 2019)
- Amended and Restated Registration Rights Agreement dated May 16, 2019 by and among the Registrant and certain of its stockholders (Filed With SEC on August 20, 2019)
- Contribution and Subscription Agreement dated January 24, 2018 between the Registrant and Lung Therapeutics, Inc (Filed With SEC on August 20, 2019)
- Securities Purchase Agreement dated March 13, 2018 by and among the Registrant and the Buyers named therein (Filed With SEC on August 20, 2019)
- Securities Purchase Agreement dated May 16, 2019 by and among the Registrant and the Buyers named therein (Filed With SEC on August 20, 2019)
